These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Trimodality therapy for malignant pleural mesothelioma: results from an EORTC phase II multicentre trial. Van Schil PE; Baas P; Gaafar R; Maat AP; Van de Pol M; Hasan B; Klomp HM; Abdelrahman AM; Welch J; van Meerbeeck JP; Eur Respir J; 2010 Dec; 36(6):1362-9. PubMed ID: 20525721 [TBL] [Abstract][Full Text] [Related]
8. Thoracic stop-flow perfusion in the treatment of refractory malignant pleural mesothelioma: a phase I-II evaluation/trial. Guadagni S; Clementi M; Valenti M; Fiorentini G; Cantore M; Kanavos E; Amicucci G In Vivo; 2006; 20(6A):715-8. PubMed ID: 17203752 [TBL] [Abstract][Full Text] [Related]
9. Survival after trimodality therapy for malignant pleural mesothelioma: Radical Pleurectomy, chemotherapy with Cisplatin/Pemetrexed and radiotherapy. Bölükbas S; Manegold C; Eberlein M; Bergmann T; Fisseler-Eckhoff A; Schirren J Lung Cancer; 2011 Jan; 71(1):75-81. PubMed ID: 19765853 [TBL] [Abstract][Full Text] [Related]
10. Multimodality therapy in mesothelioma: role of chemotherapy. Vogelzang NJ Thorac Surg Clin; 2004 Nov; 14(4):531-42. PubMed ID: 15559060 [TBL] [Abstract][Full Text] [Related]
11. Results of a phase II trial of combined chemotherapy for patients with diffuse malignant mesothelioma of the pleura. Kasseyet S; Astoul P; Boutin C Cancer; 1999 Apr; 85(8):1740-9. PubMed ID: 10223568 [TBL] [Abstract][Full Text] [Related]
12. Extrapleural pneumonectomy followed by intracavitary intraoperative hyperthermic cisplatin with pharmacologic cytoprotection for treatment of malignant pleural mesothelioma: a phase II prospective study. Tilleman TR; Richards WG; Zellos L; Johnson BE; Jaklitsch MT; Mueller J; Yeap BY; Mujoomdar AA; Ducko CT; Bueno R; Sugarbaker DJ J Thorac Cardiovasc Surg; 2009 Aug; 138(2):405-11. PubMed ID: 19619785 [TBL] [Abstract][Full Text] [Related]
13. Advances in the diagnosis, evaluation, and management of malignant pleural mesothelioma. Sterman DH; Albelda SM Respirology; 2005 Jun; 10(3):266-83. PubMed ID: 15955137 [TBL] [Abstract][Full Text] [Related]
14. [Development in the treatment of malignant mesothelioma]. Bass P; Burgers JA Ned Tijdschr Geneeskd; 2005 Apr; 149(14):747-53. PubMed ID: 15835625 [TBL] [Abstract][Full Text] [Related]
15. Cold-plasma coagulation in the treatment of malignant pleural mesothelioma: results of a combined approach. Hoffmann M; Bruch HP; Kujath P; Limmer S Interact Cardiovasc Thorac Surg; 2010 Apr; 10(4):502-5. PubMed ID: 20075037 [TBL] [Abstract][Full Text] [Related]
16. Outcome after extrapleural pneumonectomy for malignant pleural mesothelioma. Aigner C; Hoda MA; Lang G; Taghavi S; Marta G; Klepetko W Eur J Cardiothorac Surg; 2008 Jul; 34(1):204-7. PubMed ID: 18407510 [TBL] [Abstract][Full Text] [Related]
17. [Treatment of malignant pleural mesothelioma]. Yusa T Gan To Kagaku Ryoho; 2007 Apr; 34(4):520-6. PubMed ID: 17431335 [TBL] [Abstract][Full Text] [Related]
18. Radical pleurectomy/decortication and intraoperative radiotherapy followed by conformal radiation with or without chemotherapy for malignant pleural mesothelioma. Lee TT; Everett DL; Shu HK; Jahan TM; Roach M; Speight JL; Cameron RB; Phillips TL; Chan A; Jablons DM J Thorac Cardiovasc Surg; 2002 Dec; 124(6):1183-9. PubMed ID: 12447185 [TBL] [Abstract][Full Text] [Related]
19. A phase II study of intrapleural immuno-chemotherapy, pleurectomy/decortication, radiotherapy, systemic chemotherapy and long-term sub-cutaneous IL-2 in stage II-III malignant pleural mesothelioma. Lucchi M; Chella A; Melfi F; Dini P; Ambrogi M; Fino L; Fontanini G; Mussi A Eur J Cardiothorac Surg; 2007 Mar; 31(3):529-33; discussion 533-4. PubMed ID: 17188885 [TBL] [Abstract][Full Text] [Related]
20. Current concepts in malignant pleural mesothelioma. Kaufman AJ; Pass HI Expert Rev Anticancer Ther; 2008 Feb; 8(2):293-303. PubMed ID: 18279069 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]